EUVIMEDEUVIMED entdecken
Open Access

Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice

Ping Bai, Yan Liu, Liuyue Yang, Weihua Ding iD, Prasenjit Mondal iD, Na Sang, Gang Liu, Xiaoxia Lu, Thanh Tu Ho iD, Yanting Zhou, Rui Wu, Vishal C Birar und 7 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c01491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Ping Bai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, West China Hospital, Sichuan University, C…. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Neuralgia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have shown that the epigenetic protein histone deacetylase 11 (HDAC11) is highly expressed in the brain and critically modulates neuroimmune functions, making it a potential therapeutic target for neurological disorders. Herein, we report the development of PB94, which is a novel HDAC11 inhibitor. PB94 exhibited potency and selectivity against HDAC11 with IC50 = 108 nM and >40-fold selectivity over other HDAC isoforms. Pharmacokinetic/pharmacodynamic evaluation indicated that PB94 possesses promising drug-like properties. Additionally, PB94 was radiolabeled with carbon-11 as [11C]PB94 for positron emission tomography (PET), which revealed significant brain uptake and metabolic properties suitable for drug development in live animals. Furthermore, we demonstrated that neuropathic pain was associated with brain upregulation of HDAC11 and that pharmacological inhibition of HDAC11 by PB94 ameliorated neuropathic pain in a mouse model. Collectively, our findings support further development of PB94 as a selective HDAC11 inhibitor for neurological indications, including pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroinflammatory DiseasesNeuralgiaAnimalsMiceBrainHistone DeacetylasesHistone Deacetylase Inhibitors

Substanzen

Histone DeacetylasesHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Institute of Respiratory Health, Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, Chi…
  • Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu, Sichuan 610041, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Chengdu, Sichuan 610041, China.
  • Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States.

ORCID-Profile: Weihua Ding, Prasenjit Mondal, Thanh Tu Ho, Hening Lin, Can Zhang, Weimin Li, Changning Wang

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Bai, P., Liu, Y., Yang, L., Ding, W., Mondal, P., Sang, N., Liu, G., Lu, X., Ho, T. T., Zhou, Y., Wu, R., Birar, V. C., Wilks, M. Q., Tanzi, R. E., Lin, H., Zhang, C., Li, W., Shen, S., & Wang, C. (2023). Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01491

Vancouver

Bai P, Liu Y, Yang L, Ding W, Mondal P, Sang N, et al. Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01491

BibTeX
@article{Bai2023,
  author = {Bai, Ping and Liu, Yan and Yang, Liuyue and Ding, Weihua and Mondal, Prasenjit and Sang, Na and Liu, Gang and Lu, Xiaoxia and Ho, Thanh Tu and Zhou, Yanting and Wu, Rui and Birar, Vishal C and Wilks, Moses Q and Tanzi, Rudolph E and Lin, Hening and Zhang, Can and Li, Weimin and Shen, Shiqian and Wang, Changning},
  title = {Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c01491}
}
Kostenlos starten →